Jeffrey W. Sherman, MD, FACP
Board Member
Larimar Therapeutics, Inc. (LRMR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey W. Sherman, MD, FACP
Jeffrey W. Sherman, MD, FACP is recorded as Board Member at Larimar Therapeutics, Inc. (LRMR). Larimar Therapeutics, Inc. reported in an 8-K filed October 3, 2023 that Jeffrey W. Sherman, MD, FACP was appointed Class I director, with an initial term expiring at the Company's 2024 Annual Meeting of Stockholders, and a member of the Nomina, effective October 3, 2023.
“On October 3, 2023 (the "Appointment Date"), the Board of Directors (the "Board") of Larimar Therapeutics, Inc. (the "Company") increased the size of the Board from five to six members and, upon recommendation of the Nominating and Corporate Governance Committee, appointed Jeffrey W. Sherman, MD, FACP to serve as a Class I director, with an initial term expiring at the Company's 2024 Annual Meeting of Stockholders, and a member of the Nominating and Corporate Governance Committee.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-10-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Larimar Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carole Ben-Maimon CEO, Board Member
- Carole S. Ben-Maimon CEO, Board Member
- Joseph Truitt Chairman, Board Member
- Michael Celano CFO
- John B. Harlow, Jr. COO
- Frank E. Thomas Board Member
- Jonathan Leff Board Member
- Thomas E. Hamilton Board Member
- Thomas Edward Hamilton Board Member
- Thomas O. Daniel Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.